alzheimer
New Alzheimer’s Drug Slows Early Stages Of Disease
A new study revealed that Lilly Biotechnology Center’s Alzheimer’s drug slowed the disease by as much as 22% to 35%, compared to a separate placebo study.
Alzheimer's drug
FDA grants first full approval for an Alzheimer’s drug
For the first time in more than 20 years an Alzheimer’s medicine, from Eisai and Biogen (BIIB), has received standard FDA clearance.